Efficacy and endocrine effects of medical treatment of endometriosis.
Melis
G B
GB
Department of Obstetrics and Gynecology, University of Cagliari, School of Medicine, Italy.
Mais
V
V
Paoletti
A M
AM
Ajossa
S
S
Guerriero
S
S
Fioretti
P
P
D000293:Adolescent; D000328:Adult; D002064:Buserelin / Q000592:standards / Q000627:therapeutic use*; D003613:Danazol / Q000592:standards / Q000627:therapeutic use*; D004715:Endometriosis / Q000175:diagnosis / Q000188:drug therapy* / Q000378:metabolism; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D005867:Gestrinone / Q000592:standards / Q000627:therapeutic use*; D006801:Humans; D007031:Hypothalamus / Q000187:drug effects*; D010535:Laparoscopy; D007986:Luteinizing Hormone / Q000097:blood; D008875:Middle Aged; D010902:Pituitary Gland / Q000187:drug effects*; D011374:Progesterone / Q000097:blood
D005867:Gestrinone; D011374:Progesterone; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D003613:Danazol; D002064:Buserelin